About
Story
People
Careers
Technology
Pipeline
News & Blog
In the News
Our blog
Contact us
Pipeline
We take aim at the world’s most intractable diseases. Our portfolio spans both novel and known (but traditionally undruggable) targets.
Indication
rModality
Target
Discovery
Pre-clinical
Clinical
IL-2
Cancer
Metabolic
Immunity
Cancer
Auto-immune
Alzeimer's disease
MYC
Inframmation
Auto-immune
SM
Inframmation
Auto-immune
SM
SM
SM
SM
IL-1β
IL-1
β
SM
IL-1α
PTPN2
Cancer
Auto-immune
Inframmation
Auto-immune
ALS
Alzeimer's disease
ALS
1
Alzeimer's disease
IL-1RA
SM
ASO
FLCN
FLCN
Unless otherwise indicated, the rModality is a small molecule
rModality = RNA-targeted modality
